311
Views
46
CrossRef citations to date
0
Altmetric
Original Article

Mini ReviewCalcitonin

&
Pages 217-224 | Published online: 07 Aug 2009

References

  • Anusaksathien, O., Laplace, C., Li, X., Ren, Y., Peng, L., Goldring, S.R. and Galson, D.L. (2001) "Tissue-specific and ubiquitous promoters direct the expression of alternatively spliced transcripts from the calcitonin receptor gene", J. Biol. Chem. 276, 22663–22674.
  • Asrari, M. and Lobner, D. (2001) "Calcitonin potentiates oxygen-glucose deprivation-induced neuronal death", Exp. Neurol. 167, 183-188. Born, W., Fischer, J.A. and Muff, R. (2002) "Receptors for calcitonin gene-related peptide, adrenomedullin, and amylin: the contributions of novel receptor-activity-modifying proteins", Recept. Channels 8, 201–209.
  • Braga, V., Sangalli, A., Malerba, G., Mottes, M., Mirandola, S., Gatti, D., Rossini, M., Zamboni, M. and Adami, S. (2002) "Relationship among VDR (BsmI and Fokl), COLIA1, and CTR polymorphisms with bone mass, bone turnover markers, and sex hormones in men", Calcif. Tissue Int. 70, 457–462.
  • Chakraborty, M., Chatterjee, D., Kellokumpu, S., Rasmussen, H. and Baron, R. (1991) "Cell cycle-dependent coupling of the calcitonin receptor to different G proteins", Science 251, 1078–1082.
  • Chambers, T.J. and Magnus, C.J. (1982) "Calcitonin alters behaviour of isolated osteoclasts", J. Pathol. 136, 27–39.
  • Chen, W.C. Wu, H.C. Lu, H.F. Chen, H.Y. and Tsai, F.J. (2001) "Calcitonin receptor gene polymorphism: a possible genetic marker for patients with calcium oxalate stones", Eur. Urol. 39, 716–719.
  • Chesnut, C.H. 3rd, Silverman, S., Andriano, K., Genant, H., Gimona, A., Harris, S., Kiel, D., LeBoff, M., Maricic, M., Miller, P., Moniz, C., Peacock, M., Richardson, P., Watts, N. and Baylink, D. (2000) "A randomized trial of nasal spray salmon calcitonin in post-menopausal women with established osteoporosis: the prevent recurrence of osteoporotic fractures study. PROOF Study Group", Am. J. Med. 109, 267–276.
  • Dacquin, R., Davey, R.A. Laplace, C., Levasseur, R., Morris, H.A. Goldring, S.R. Gebre-Medhin, S., Galson, D.L. Zajac, J.D. and Karsenty, G. (2004) "Amylin inhibits bone resorption while the calcitonin receptor controls bone formation in vivo", J. Cell Biol. 164, 509–514.
  • Evdokiou, A., Raggatt, L.J. Atkins, G.J. and Findlay, D.M. (1999) "Calcitonin receptor-mediated growth suppression of HEK-293 cells is accompanied by induction of p21waf1 clp1 and G2/M arrest", Mol. Endocrinol. 13, 1738–1750.
  • Findlay, D.M. Houssami, S., Lin, H.Y. Myers, D.E. Brady, C.L. Darcy, P.K. Ikeda, K., Martin, T.J. and Sexton, P.M. (1994) "Truncation of the porcine calcitonin receptor cytoplasmic tail inhibits internali-zation and signal transduction but increases receptor affinity", Mol. Endocrinol. 8, 1691–1700.
  • Findlay, D.M. Houssami, S., Christopoulos, G. and Sexton, P.M. (1996) "Homologous regulation of the rat C1a calcitonin receptor (CTR) in nonosteoclastic cells is independent of CTR messenger ribonucleic acid changes and cyclic adenosine 3',5'-monophosphate-dependent protein kinase activation", Endocrinology 137, 4576–4585.
  • Findlay, D.M. Raggatt, L.J. Bouralexis, S., Hay, S., Atkins, G.J. and Evdokiou, A. (2002) "Calcitonin decreases the adherence and survival of HEK-293 cells by a caspase-independent mechanism", J. Endocrinol. 175, 715–725.
  • Gilbert, A.M. Caltabiano, S., Koehn, F.E. Chen, Z.J. Francisco, G.D. Ellingboe, J.W. Kharode, Y., Mangine, A., Francis, R., TrailSmith, M. and Gralnick, D. (2002) "Pyrazolopyrimidine-2, 4-dione sulfon-amides: novel and selective calcitonin inducers", J. Med. Chem. 45, 2342–2345.
  • Hoff, A.O. Catala-Lehnen, P., Thomas, P.M. Priemel, M., Rueger, J.M. Nasonkin, I., Bradley, A., Hughes, M.R. Ordonez, N., Cote, G.J. Amling, M. and Gagel, R.F. (2002) "Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene", J. Clin. Investig. 110, 1849–1857.
  • Jagger, C., Chambers, T. and Pondel, M. (2000) "Transgenic mice reveal novel sites of calcitonin receptor gene expression during development", Biochem. Biophys. Res. Commun. 274, 124–129.
  • Kajiya, H., Okamoto, F., Fukushima, H. and Okabe, K. (2003) "Calcitonin inhibits proton extrusion in resorbing rat osteoclasts via protein kinase A", Pflueg. Arch. 445, 651–658.
  • Katafuchi, T., Kikumoto, K., Hamano, K., Kangawa, K., Matsuo, H. and Minamino, N. (2003) "Calcitonin receptor-stimulating peptide, a new member of the calcitonin gene-related peptide family. Its isolation from porcine brain, structure, tissue distribution, and biological activity", J. Biol. Chem. 278, 12046–12054.
  • Katafuchi, T., Hamano, K. and Minamino, N. (2004) "Identification, structural determination, and biological activity of bovine and canine calcitonin receptor-stimulating peptides", Biochem. Biophys. Res. Commun. 313, 74–79.
  • Kiriyama, Y., Tsuchiya, H., Murakami, T., Satoh, K. and Tokumitsu, Y. (2001) "Calcitonin induces IL-6 production via both PKA and PKC pathways in the pituitary folliculo-stellate cell line", Endocrinology 142, 3563–3569.
  • Li, Q., Wang, J., Armant, D.R. Bagchi, M.K. and Bagchi, I.C. (2002) "Calcitonin down-regulates E-cadherin expression in rodent uterine epithelium during implantation", J. Biol. Chem. 277, 46447–46455.
  • Malgaroli, A., Meldolesi, J., Zallone, A.Z. andTeti, A. (1989) "Controlof cytosolic free calcium in rat and chicken osteoclasts. The role of extracellular calcium and calcitonin", J. Biol. Chem. 264, 14342–14347.
  • Martin, T.J. Moseley, J.M. and Sexton, P.M. (2001) "Calcitonin", In: DeGroot, L.J. and Jameson, J.L. eds, Endocrinology, 4th Ed. (W.B. Saunders Company, Philadelphia), pp 999–1008.
  • Martinez, M.J. Roque, M., Alonso-Coello, P., Catala, E., Garcia, J.L. and Ferrandiz, M. (2003) "Calcitonin for metastatic bone pain", Cochrane Database Syst. Rev., (3):CD003223.
  • Masi, L., Becherini, L., Colli, E., Gennari, L., Mansani, R., Falchetti, A., Becorpi, A.M. Cepollaro, C., Gonnelli, S., Tanini, A. and Brandi, M.L. (1998) "Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women", Biochem. Biophys. Res. Commun. 248, 190–195.
  • Morfis, M., Christopoulos, A. and Sexton, P.M. (2003) "RAMPs: 5 years on, where to now?", Trends Pharmacol. Sci. 24, 596–601.
  • Nakamura, M., Zhang, Z.Q. Shan, L., Hisa, T., Sasaki, M., Tsukino, R., Yokoi, T., Kaname, A. and Kakudo, K. (1997) "Allelic variants of human calcitonin receptor in the Japanese population", Hum. Genet. 99, 38–41.
  • Nakamura, M., Morimoto, S., Zhang, Z., Utsunomiya, H., Inagami, T., Ogihara, T. and Kakudo, K. (2001) "Calcitonin receptor gene polymorphism in Japanese women: correlation with body mass and bone mineral density", Calcif. Tissue Int. 68, 211–215.
  • Ng, K.W. Livesey, S.A. Larkins, R.G. and Martin, T.J. (1983) "Calcitonin effects on growth and on selective activation of type II isoenzyme of cyclic adenosine 3':5'-monophosphate-dependent protein kinase in T 47D human breast cancer cells", Cancer Res. 43, 794–800.
  • Nosaka, Y., Tachi, Y., Shimpuku, H., Kawamura, T. and Ohura, K. (2002) "Association of calcitonin receptor gene polymorphism with early marginal bone loss around endosseous implants", Int. J. Oral Maxillofac. Implants 17, 38–43.
  • Nygaard, S.C. Kuestner, R.E. Moore, E.E. and Stroop, S.D. (1997) "Phosphorylation of the human calcitonin receptor by multiple kinases is localized to the C-terminus", J. Bone Miner. Res. 12, 1681–1690.
  • Offermanns, S., Iida-Klein, A., Segre, G.V. and Simon, M.I. (1996) "G alpha q family members couple parathyroid hormone (PTH)/PTH-related peptide and calcitonin receptors to phospholipase C in COS-7 cells", Mol. Endocrinol. 10, 566–574.
  • Plotkin, L.I. Weinstein, R.S. Parfitt, A.M. Roberson, P.K. Manolagas, S.C. and Bellido, T. (1999) "Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin", J. Clin. Investig. 104, 1363–1374.
  • Poyner, D.R. Sexton, P.M. Marshall, I., Smith, D.M. Quirion, R., Born, W., Muff, R., Fischer, J.A. and Foord, S.M. (2002) "International Union of Pharmacology. XXXII. The mammalian calcitonin gene-related peptides, adrenomedullin, amylin, and calcitonin receptors", Pharmacol. Rev. 54, 233–246.
  • Raggatt, L.-J., Evdokiou, A. and Findlay, D.M. (2000) "Sustained activation of Erk1/2 MAPK and cell growth suppression by the insert negative, but not the insert-positive isoform of the human calcitonin receptor", J. Endocrinol. 167, 93–105.
  • Rakopoulos, M., Ikegame, M., Findlay, D.M. Martin, T.J. and Moseley, J.M. (1995) "Short treatment of osteoclasts in bone marrow culture with calcitonin causes prolonged suppression of calcitonin receptor mRNA", Bone 17, 447–453.
  • Roh, J., Chang, C.L. Bhalla, A., Klein, C. and Hsu, S.Y. (2004) "Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes", J. Biol. Chem. 279, 7264–7274.
  • Salido, M., Vilches, J. and Lopez, A. (2000) "Neuropeptides bombesin and calcitonin induce resistance to etoposide induced apoptosis in prostate cancer cell lines", Histol. Histopathol. 15, 729–738.
  • Samura, A., Wada, S., Suda, S., Iitaka, M. and Katayama, S. (2000) "Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor", Endocrinology 141, 3774–3782.
  • Santhanagopal, A., Chidiac, P., Horne, W.C. Baron, R. and Dixon, S.J. (2001) "Calcitonin (CT) rapidly increases NA(+ )/H(+) exchange and metabolic acid production: effects mediated selectively by the C1A CT receptor isoform", Endocrinology 142, 4401–4413.
  • Schaaf, M.J. and Cidlowski, J.A. (2002) "AUUUA motifs in the 3'UTR of human glucocorticoid receptor alpha and beta mRNA destabilize mRNA and decrease receptor protein expression", Steroids 67, 627–636.
  • Seck, T., Baron, R. and Horne, W.C. (2003) "The alternatively spliced deltae13 transcript of the rabbit calcitonin receptor dimerizes with the C1a isoform and inhibits its surface expression", J. Biol. Chem. 278, 23085–23093.
  • Selander, K.S. Harkonen, P.L. Valve, E., Monkonen, J., Hannuniemi, R. and Vaananen, H.K. (1996) "Calcitonin promotes osteoclast survival in vitro", Mol. Cell. Endocrinol. 122, 119–129.
  • Sexton, P.M. (1991) "Central nervous system binding sites for calcitonin and calcitonin gene-related peptide", Mol. Neurobiol. 251, 251–273.
  • Sexton, P.M. Findlay, D.M. and Martin, T.J. (1999) "Calcitonin", Curr. Med. Chem. 6, 1067–1093.
  • Sexton, P.M. Albiston, A., Morfis, M. and Tilakaratne, N. (2001) "Receptor activity modifying proteins", Cell. Signal. 13, 73–83.
  • Shah, G.V. Rayford, W., Noble, M.J. Austenfeld, M., Weigel, J., Vamos, S. and Mebust, W.K. (1994) "Calcitonin stimulates growth of human prostate cancer cells through receptor-mediated increase in cyclic adenosine 3',5'-monophosphates and cytoplasmic Ca2+ transients", Endocrinology 134, 596–602.
  • Silver, I.A. Murrills, R.J. and Etherington, D.J. (1988) "Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts", Exp. Cell Res. 175, 266–276.
  • Silverman, S.L. and Azria, M. (2002) "The analgesic role of calcitonin following osteoporotic fracture", Osteoporos. Int. 13, 858–867.
  • Slisli, Y. and de Beaurepaire, R. (1999) "Interleukin-1beta and calcitonin, but not corticotropin-releasing factor, alter sleep cycles when injected into the rat hypothalamic lateral paraventricular area", Neurosci. Lett. 265, 29–32.
  • Stroop, S.D. Thompson, D.L. Kuestner, R.E. and Moore, E.E. (1993) "A recombinant human calcitonin receptor functions as an extracellular calcium sensor", J. Biol. Chem. 268, 19927–19930.
  • Tsai, F.J. Chen, W.C. Chen, H.Y. and Tsai, C.H. (2003) "The ALUI calcitonin receptor gene polymorphism (TT) is associated with low bone mineral density and susceptibility to osteoporosis in post-menopausal women", Gynecol. Obstet. Investig. 55, 82–87.
  • Wada, S., Udagawa, N., Nagata, N., Martin, T.J. and Findlay, D.M. (1996) "Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism", Endocrinology 137, 312–320.
  • Wada, S., Udagawa, N., Akatsu, T., Nagata, N., Martin, T.J. and Findlay, D.M. (1997) "Regulation by calcitonin and glucocorticoids of calcitonin receptor gene expression in mouse osteoclasts", Endocrinology 138, 521–529.
  • Wang, J., Rout, U.K. Bagchi, I.C. and Armant, D.R. (1998) "Expression of calcitonin receptors in mouse preimplantation embryos and their function in the regulation of blastocyst differentiation by calcitonin", Development 125, 4293–4302.
  • Wolfe, L.A. 3rd, Fling, M.E. Xue, Z., Armour, S., Kerner, S.A. Way, J., Rimele, T. and Cox, R.F. (2003) "In vitro characterization of a human calcitonin receptor gene polymorphism", Mutat. Res. 522, 93–105.
  • Yamaguchi, M. (1991) "Stimulatory effect of calcitonin on Ca2+ inflow in isolated rat hepatocytes", Mol. Cell. Endocrinol. 75, 65–70.
  • Yamamoto, M., Seedor, J.G. Rodan, G.A. and Balena, R. (1995) "Endogenous calcitonin attenuates parathyroid hormone-induced cancellous bone loss in the rat", Endocrinology 136, 788–795.
  • Zhang, Z., Hernandez-Lagunas, L., Horne, W.C. and Baron, R. (1999) "Cytoskeleton-dependent tyrosine phosphorylation of the p130(Cas) family member HEF1 downstream of the G protein-coupled calcitonin receptor. Calcitonin induces the association of HEF1, paxillin, and focal adhesion kinase", J. Biol. Chem. 274, 25093–25098.
  • Zhang, Z., Baron, R. and Horne, W.C. (2000) "Integrin engagement, the actin cytoskeleton, and c-Src are required for the calcitonin-induced tyrosine phosphorylation of paxillin and HEF1, but not for calcitonin-induced Erk1/2 phosphorylation", J. Biol. Chem. 275, 37219–37223.
  • Zhang, Z., Neff, L., Bothwell, A.L. Baron, R. and Horne, W.C. (2002) "Calcitonin induces dephosphorylation of Pyk2 and phosphorylation of focal adhesion kinase in osteoclasts", Bone 31, 359–365.
  • Zhu, L.J. Cullinan-Bove, K., Polihronis, M., Bagchi, M.K. and Bagchi, I.C. (1998) "Calcitonin is a progesterone-regulated marker that forecasts the receptive state of endometrium during implantation", Endocrinology 139, 3923–3934.
  • Zofkova, I., Zajickova, K., Hill, M. and Krepelova, A. (2003) "Does polymorphism C1377T of the calcitonin receptor gene determine bone mineral density in postmenopausal women?", Exp. Clin. Endocrinol. Diabetes 111, 447–449.
  • Zolnierowicz, S., Cron, P., Solinas-Toldo, S., Fries, R., Lin, H.Y. and Hemmings, B.A. (1994) "Isolation, characterization, and chromosomal localization of the porcine calcitonin receptor gene. Identification of two variants of the receptor generated by alternative splicing", J. Biol. Chem. 269, 19530–19538.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.